Regulation of angiogenesis via vascular endothelial growth factor receptors.
By Tanja Veikkola, M. Karkkainen, L. Claesson‐Welsh, K. Alitalo. Cancer Research, 2000
773 citations recorded by the source corpus.
View Paper: https://www.semanticscholar.org/paper/f572e82b977c8380010ed105d10aea12e3ee9b85
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- N. Ferrara
- Rakesh K. Jain
- Peter Carmeliet
- D. Hicklin
- M. Shibuya
- A. Luttun
- L. Moons
- R. Mokhtari
Citations in the corpus
- Role of vascular endothelial growth factor in regulation of physiological angiogenesis. (2001, background): “For a comprehensive review of the molecular properties and clinical applications of VEGF and other members of the VEGF gene family, refer to several recent review articles (29, 30, 64, 78, 82, 110).”
- The protein tyrosine kinase family of the human genome (2000, background): “…TIE Partanen and Dumont, 1999; Tallquist et al., 1999 TRK Hallbook, 1999; Kaplan and Miller, 1997; Barbacid, 1995; 1994 VEGFR Gerwins et al., 2000; Veikkola et al., 2000; Neufeld et al., 1999 AATYK Gaozza et al., 1997 Oncogene Table 2a Summary and classi®cation of human non-receptor tyrosine…”
- Abnormal lymphatic vessel development in neuropilin 2 mutant mice. (2002, background): “The biological effects of these growth factors are mediated by binding to three EC tyrosine kinase receptors, VEGFR1-VEGFR3 (for reviews, see Neufeld et al., 1999; Veikkola et al., 2000).”
- Combination therapy in combating cancer (2017, background): “Mechanistically, drugs that inhibit angiogenesis deprive tumour cells of vital nutrients and oxygen, and therefore they suppress tumor growth and progression [152].”
- Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1 (2002, background): “Luttun et al.(5) analyzed the role of PlGF in the stimulation of angiogenesis and development of collateral vessels, which serve to bypass an artery obstructed by atherosclerotic lesions in the ischemic heart or limb.”